ACROBiosystems

PharmaceuticalsSeries BBeijing, Chinaacrobiosystems.cn

Latest round

Series B

Last raised

Apr 2017

Total raised

Undisclosed

Investors

6

About ACROBiosystems

Established in 2010 and based in Beijing, China, ACROBiosystems is a biotech company that provides target antigens and other key reagents and related services required in the development of targeted therapeutic drugs. In 2021, the company was listed on the Shenzhen Stock Exchange. The company engages in the research and development of recombinant proteins. Its main products include ADC target protein, immune checkpoint protein and multiple transmembrane target protein, etc. Its main products include ADC target protein, immune checkpoint protein and multiple transmembrane target protein, etc.

Who invested in ACROBiosystems

6 investors across 2 rounds

See all investors in ACROBiosystems

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Apr 20, 2017

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Aug 24, 2015

    Amount

    Undisclosed

    Investors

    Locked

Questions about ACROBiosystems

Who invested in ACROBiosystems?

ACROBiosystems has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ACROBiosystems raised?

ACROBiosystems has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did ACROBiosystems last raise money?

ACROBiosystems's most recent round on record is a Series B, in Apr 2017.

What does ACROBiosystems do?

Established in 2010 and based in Beijing, China, ACROBiosystems is a biotech company that provides target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.

Where is ACROBiosystems headquartered?

ACROBiosystems is headquartered in Beijing, China.

Which VCs invest in companies like ACROBiosystems?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at ACROBiosystems's stage. Their profiles are linked below.

Raising like ACROBiosystems? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.